Company chart and information is provided by TradingView based on 15-minute-delayed data.
Vascular Biogenics Ltd is an Israel-based clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of first-in-class treatments for cancer. The lead product candidate of the company is VB-111 which is a gene-based biologic which is being developed for solid tumor indications for recurrent glioblastoma, an aggressive form of brain cancer. The company is also engaged in conducting a program targeting anti-inflammatory diseases, based on the use of Lecinoxoid platform technology. The product brands of the company include VTS, Vascular Targeting Systems, Vbl, Vascular Biogenics And Vascular Therapeutics.
Website: | www.vblrx.com |
Email: | IR@VBLRX.COM |
Main Phone: | +972 89935000 |
Address: | 8 HaSatat Street |
City / Town: | Modi'in |
Country: | IL |
Postal Code: | 7178106 |
Exchange: | NSD |
CEO: | Dror Harats |
Employees: | 38 |
NAICS: | Pharmaceutical P |
Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
Open N/A | High N/A | Low N/A | Prev Close N/A |
Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |